Inventory of Federal Drug-related Data Resources
Author | : United States. Office of National Drug Control Policy |
Publisher | : |
Total Pages | : 244 |
Release | : 1995 |
Genre | : Drug abuse |
ISBN | : |
Download Inventory Of Federal Drug Related Data Resources full books in PDF, epub, and Kindle. Read online free Inventory Of Federal Drug Related Data Resources ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : United States. Office of National Drug Control Policy |
Publisher | : |
Total Pages | : 244 |
Release | : 1995 |
Genre | : Drug abuse |
ISBN | : |
Author | : United States. Office of National Drug Control Policy. Drug Control Research, Data, and Evaluation Committee |
Publisher | : |
Total Pages | : 256 |
Release | : 2003 |
Genre | : Drug control |
ISBN | : |
Author | : Barry Leonard |
Publisher | : |
Total Pages | : 243 |
Release | : 2005-03-01 |
Genre | : |
ISBN | : 9780756746483 |
This Report by the Office of Nat. Drug Control Policy's (ONDCP) Advisory Committee on Drug Control Research, Data, & Evaluation (DCRDE) discusses some of the work & products that ONDCP & its Federal partners have engaged in over several years. The work of the DCRDE & its three Subcommittees is to define & coordinate the research agenda for national drug control. This Report discusses some of the issues, & documents some of the actions & accomplishments in this regard. Additionally, the Report provides an update to information regarding ONDCP's legislative mandates & reporting requirements.
Author | : United States Sentencing Commission |
Publisher | : |
Total Pages | : 556 |
Release | : 1988 |
Genre | : Criminal justice, Administration of |
ISBN | : |
Author | : United States. Office of National Drug Control Policy. Drug Control Research, Data, and Evaluation Committee |
Publisher | : |
Total Pages | : 264 |
Release | : 2003 |
Genre | : Drug control |
ISBN | : |
Author | : Institute of Medicine |
Publisher | : National Academies Press |
Total Pages | : 286 |
Release | : 2009-12-30 |
Genre | : Medical |
ISBN | : 0309140129 |
The goal of eliminating disparities in health care in the United States remains elusive. Even as quality improves on specific measures, disparities often persist. Addressing these disparities must begin with the fundamental step of bringing the nature of the disparities and the groups at risk for those disparities to light by collecting health care quality information stratified by race, ethnicity and language data. Then attention can be focused on where interventions might be best applied, and on planning and evaluating those efforts to inform the development of policy and the application of resources. A lack of standardization of categories for race, ethnicity, and language data has been suggested as one obstacle to achieving more widespread collection and utilization of these data. Race, Ethnicity, and Language Data identifies current models for collecting and coding race, ethnicity, and language data; reviews challenges involved in obtaining these data, and makes recommendations for a nationally standardized approach for use in health care quality improvement.
Author | : United States. Social and Rehabilitation Service |
Publisher | : |
Total Pages | : 460 |
Release | : 1975 |
Genre | : Medicaid |
ISBN | : |
Author | : Agency for Healthcare Research and Quality/AHRQ |
Publisher | : Government Printing Office |
Total Pages | : 385 |
Release | : 2014-04-01 |
Genre | : Medical |
ISBN | : 1587634333 |
This User’s Guide is intended to support the design, implementation, analysis, interpretation, and quality evaluation of registries created to increase understanding of patient outcomes. For the purposes of this guide, a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes. A registry database is a file (or files) derived from the registry. Although registries can serve many purposes, this guide focuses on registries created for one or more of the following purposes: to describe the natural history of disease, to determine clinical effectiveness or cost-effectiveness of health care products and services, to measure or monitor safety and harm, and/or to measure quality of care. Registries are classified according to how their populations are defined. For example, product registries include patients who have been exposed to biopharmaceutical products or medical devices. Health services registries consist of patients who have had a common procedure, clinical encounter, or hospitalization. Disease or condition registries are defined by patients having the same diagnosis, such as cystic fibrosis or heart failure. The User’s Guide was created by researchers affiliated with AHRQ’s Effective Health Care Program, particularly those who participated in AHRQ’s DEcIDE (Developing Evidence to Inform Decisions About Effectiveness) program. Chapters were subject to multiple internal and external independent reviews.
Author | : National Survey on Drug Use and Health (U.S.) |
Publisher | : |
Total Pages | : 320 |
Release | : 2008 |
Genre | : Drug abuse |
ISBN | : |
Author | : National Academies of Sciences, Engineering, and Medicine |
Publisher | : National Academies Press |
Total Pages | : 483 |
Release | : 2017-09-28 |
Genre | : Medical |
ISBN | : 0309459575 |
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.